Perioperative Management to Reduce Cardiovascular Events

Circulation. 2016 Mar 15;133(11):1125-30. doi: 10.1161/CIRCULATIONAHA.115.017787.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Anesthesia / adverse effects
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Arthroplasty, Replacement, Knee
  • Aspirin / adverse effects
  • Aspirin / therapeutic use
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Clinical Trials as Topic
  • Clopidogrel
  • Contraindications
  • Coronary Disease / complications
  • Coronary Disease / therapy
  • Disease Susceptibility
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypolipidemic Agents / therapeutic use
  • Male
  • Perioperative Care / methods*
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control*
  • Postoperative Hemorrhage / chemically induced
  • Preanesthetic Medication
  • Risk Factors
  • Risk Reduction Behavior
  • Stress, Physiological
  • Surgical Procedures, Operative / adverse effects
  • Thrombophilia / drug therapy
  • Thrombophilia / etiology
  • Ticlopidine / analogs & derivatives

Substances

  • Adrenergic beta-Antagonists
  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Clopidogrel
  • Ticlopidine
  • Aspirin